Jupiter Neurosciences Inc (JUNS)

$4.40 +0.13 (3.04%)
Market Cap 141.35M
Revenue (ttm) 0.00
Net Income (ttm) -4.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 115,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 33.10M
Stochastic %K 5%
Beta N/A
Analysts Strong Sell
Price Target $30.00

Latest News on JUNS

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 6 weeks ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 6 weeks ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Aug 16, 2022, 5:48 PM EDT - 2 years ago

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO